EMPOWER: Randomized Trial of Online Chronic Pain Management Program to Reduce Reliance on Opioid Analgesic Medications
| Status: | Enrolling by invitation |
|---|---|
| Conditions: | Chronic Pain, Chronic Pain |
| Therapuetic Areas: | Musculoskeletal |
| Healthy: | No |
| Age Range: | 25 - 80 |
| Updated: | 4/17/2018 |
| Start Date: | February 5, 2018 |
| End Date: | January 2022 |
EMPOWER: Evaluating the Ability to Reduce Morphine Equivalent Dose for Chronic Pain Patients Receiving Opioid-therapy Through a Web-based E-Health Self-management Program: a Randomized Multi-site Clinical Trial in Primary Care
This is a 10-month internet-based randomized controlled trial to evaluate whether an online
chronic pain management program ("E-Health") can assist with reduced opioid reliance in
chronic pain patients. About half of the eligible participants will receive access to the
E-Health program in addition to their standard chronic pain treatment; the other half will
just continue receiving their standard chronic pain treatment.
chronic pain management program ("E-Health") can assist with reduced opioid reliance in
chronic pain patients. About half of the eligible participants will receive access to the
E-Health program in addition to their standard chronic pain treatment; the other half will
just continue receiving their standard chronic pain treatment.
This study will determine whether an innovative, accessible E-health intervention can assist
with reduced opioid reliance in chronic pain patients, which can, ultimately, reduce risks of
unintended opioid overdose and death. Importantly, the study will contribute to a better
understanding of the mechanisms contributing to opioid use reduction while managing pain. The
findings may assist in developing treatment options for a population at risk for opioid
adverse effects.
Potential participants will be identified through electronic health record (EHR) queries at
participating sites. Participants will be assessed at baseline, at the end of the 4-month
treatment period, and at 6 months following end-of-treatment through an electronic data
capture system accessed by the participants. Other outcome data will be obtained from the
participant's EHR data.
with reduced opioid reliance in chronic pain patients, which can, ultimately, reduce risks of
unintended opioid overdose and death. Importantly, the study will contribute to a better
understanding of the mechanisms contributing to opioid use reduction while managing pain. The
findings may assist in developing treatment options for a population at risk for opioid
adverse effects.
Potential participants will be identified through electronic health record (EHR) queries at
participating sites. Participants will be assessed at baseline, at the end of the 4-month
treatment period, and at 6 months following end-of-treatment through an electronic data
capture system accessed by the participants. Other outcome data will be obtained from the
participant's EHR data.
Inclusion Criteria:
- Be 25-80 years of age
- Be able to understand the study, and having understood, provide informed consent in
English
- Have a daily average prescribed MED ≥ 20 mg over a recent three-month period
- Have a chronic pain-related diagnosis
- Self-report current use of opioid medication(s) to treat pain
- Have a Brief Pain Inventory Pain Intensity score ≥3
- Have internet access and a working email account
Exclusion Criteria:
- Be anyone who, in the judgment of study staff, would be unlikely to complete the study
(e.g., planning to change to a different primary care clinic, have a terminal illness,
etc.)
- Be unwilling/unable to complete the WebNeuro assessments
- Be pregnant
- Be a prisoner
We found this trial at
1
site
Click here to add this to my saved trials
